By July 1st of each year, a manufacturer or labeler of prescription drugs that directly or indirectly distributes prescription drugs for dispensation to residents of the District shall file a report with the Department in the form and manner provided by the Department. The report shall be accompanied by payment of a fee, as set by the Department in rule, to support the work of the Department under this subchapter.
(May 18, 2004, D.C. Law 15-164, § 302, 51 DCR 3688.)
This section is referenced in § 48-833.03.
Structure District of Columbia Code
Chapter 8A - Affordability of Prescription Drugs — AccessRx Program
Subchapter III - Full Disclosure of Prescription Drug Marketing Costs
§ 48–833.01. Requirement to disclose prescription drug marketing costs
§ 48–833.02. Manner of reporting
§ 48–833.03. Content of annual report by manufacturer or labeler
§ 48–833.04. Department reports